Katerndahl D A, Trammell C
Department of Family Practice, University of Texas Health Science Center-San Antonio 78284-7795, USA.
J Fam Pract. 1997 Jul;45(1):54-63.
The purpose of this study was to document the prevalence of panic states in patients presenting with chest pain in primary care settings, to determine the recognition rate of panic states by family physicians, and to assess the impact of lack of recognition on interventions and costs.
Patients from the South Texas Ambulatory Research Network (STARNET) presenting with a new complaint of chest pain were asked to participate in the study. Before seeing their physician, subjects completed the panic disorder section of the Structured Clinical Interview (SCID) of the Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. The SCID was used to assign diagnoses of panic disorder, infrequent panic, or limited symptom attacks. Health care outcomes included medications prescribed, tests ordered, follow-up and referrals, costs, and physician diagnosis.
Although approximately one half of the 51 patients in this study met criteria for either panic disorder or infrequent panic, few were recognized by physicians as having a panic state (kappa = -.003). Patients with panic disorder were more likely to receive follow-up or referral (P = .042), incurring higher follow-up costs (P = .080). Patients with infrequent panic received more testing (P = .008), with higher costs for testing (P = .001) and higher overall costs (P = .067). Panic-diagnosis associations were found between psychotropic (P = .001) and total (P = .070) medications as well as follow-up and referral costs (P = .009).
Although common, panic states are rarely recognized in patients presenting with complaints of chest pain. The presence of panic leads to more testing, follow-up, and referral with subsequent higher costs. Failure to diagnose panic results in increased prescribing of medications, higher costs, and inappropriate pharmacotherapy.
本研究旨在记录基层医疗环境中胸痛患者惊恐状态的患病率,确定家庭医生对惊恐状态的识别率,并评估识别不足对干预措施和成本的影响。
来自南德克萨斯门诊研究网络(STARNET)的新发胸痛患者被邀请参与研究。在看医生之前,受试者完成了《精神疾病诊断与统计手册》第三版修订版结构化临床访谈(SCID)中的惊恐障碍部分。SCID用于诊断惊恐障碍、偶发性惊恐或有限症状发作。医疗保健结果包括所开药物、所做检查、随访和转诊、成本以及医生诊断。
尽管本研究中的51名患者中约有一半符合惊恐障碍或偶发性惊恐的标准,但很少有患者被医生识别为有惊恐状态(kappa = -0.003)。惊恐障碍患者更有可能接受随访或转诊(P = 0.042),随访成本更高(P = 0.080)。偶发性惊恐患者接受了更多检查(P = 0.008),检查成本更高(P = 0.001),总体成本更高(P = 0.067)。在精神药物(P = 0.001)和总药物(P = 0.070)以及随访和转诊成本(P = 0.009)之间发现了惊恐诊断关联。
尽管惊恐状态很常见,但在主诉胸痛的患者中很少被识别。惊恐状态的存在导致更多检查、随访和转诊,随后成本更高。未能诊断出惊恐会导致药物处方增加、成本更高以及不适当的药物治疗。